Discontinuation of biosimilar infliximab in Japanese...

Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II)

Shimizu, Toshimasa, Kawashiri, Shin-Ya, Sato, Shuntaro, Morimoto, Shimpei, Minoda, Shuri, Kawazoe, Yurika, Kuroda, Shohei, Tashiro, Shigeki, Sumiyoshi, Remi, Hosogaya, Naoki, Yamamoto, Hiroshi, Kawaka
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
99
Journal:
Medicine
DOI:
10.1097/md.0000000000021480
Date:
August, 2020
File:
PDF, 293 KB
2020
Conversion to is in progress
Conversion to is failed